Medicare Enrolled

Dr. Laura Cruse, MD

Rheumatology · Tampa, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
13801 BRUCE B DOWNS BLVD STE 406, Tampa, FL 33613
8133452380
In practice since 2006 (19 years)
NPI: 1043322019 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cruse from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cruse? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cruse

Dr. Laura Cruse is a rheumatology in Tampa, FL, with 19 years in practice. Based on federal Medicare data, Dr. Cruse performed 518 Medicare services across 258 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cruse received a total of $9,498 from 40 pharmaceutical and/or device companies across 584 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cruse is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 518 Medicare services$ $9,498 industry payments

Medicare Practice Summary

Medicare Utilization ↗
518
Medicare services
Bottom 22% in FL for rheumatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
258
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~27 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)475$81$381
New patient office visit (45-59 min)43$106$499
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,498
Total received (2018-2024)
Avg $1,357/year across 7 years
Top 44% in FL for rheumatology
40
Companies
584
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,498 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$870
2023
$1,398
2022
$1,302
2021
$1,137
2020
$1,010
2019
$2,105
2018
$1,675

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AbbVie Inc.
$1,762
Amgen Inc.
$1,194
ABBVIE INC.
$987
Novartis Pharmaceuticals Corporation
$882
GENZYME CORPORATION
$471
Janssen Biotech, Inc.
$458
AbbVie, Inc.
$397
UCB, Inc.
$368
Horizon Therapeutics plc
$360
GlaxoSmithKline, LLC.
$350
Mallinckrodt Enterprises LLC
$243
Mallinckrodt Hospital Products Inc.
$229
Radius Health, Inc.
$216
E.R. Squibb & Sons, L.L.C.
$205
PFIZER INC.
$199
Genentech USA, Inc.
$176
Mallinckrodt LLC
$150
Horizon Pharma plc
$116
Celgene Corporation
$103
Zyla Life Sciences
$89
Fresenius Kabi USA, LLC
$73
Lilly USA, LLC
$60
Egalet US Inc
$47
SOBI, INC
$45
Boston Scientific Corporation
$39
Takeda Pharmaceuticals U.S.A., Inc.
$31
Merck Sharp & Dohme Corporation
$31
AstraZeneca Pharmaceuticals LP
$29
BOSTON SCIENTIFIC CORPORATION
$27
MEDAC PHARMA, INC.
$25
Sobi, Inc
$18
SANOFI-AVENTIS U.S. LLC
$17
Medtronic USA, Inc.
$15
Currax Pharmaceuticals LLC
$15
Antares Pharma, Inc.
$14
Collegium Pharmaceutical, Inc.
$14
Bioventus LLC
$12
Eisai Inc.
$12
MEDEXUS PHARMA, INC.
$11
Vertiflex, Inc.
$10
Top 3 companies account for 41.5% of total payments
Associated products mentioned in payments ›
ACTHAR · BENLYSTA · Belviq · CONTRAVE · COSENTYX · Cimzia · DUEXIS · Durolane · EVENITY · Enbrel · HUMIRA · Humira · IDACIO · INFLECTRA · INTELLIS · KEVZARA · KINERET · KRYSTEXXA · Kineret · LYRICA · ORENCIA · Otezla · Otrexup · Prolia · QULIPTA · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · Superion ISS · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tyenne · Tymlos · UBRELVY · Uloric · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XELJANZ · XTAMPZAER · ZORVOLEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,834 per 100 Medicare services performed
Looking for a rheumatology in Tampa?
Compare rheumatologys in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
55
Per 100K population
3.7
County median income
$75,011
Nearest hospital
ADVENTHEALTH TAMPA
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Cruse is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Cruse experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cruse performed 475 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cruse receive payments from pharmaceutical companies?
Yes. Dr. Cruse received a total of $9,498 from 40 companies across 584 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cruse's costs compare to other rheumatologys in Tampa?
Dr. Cruse's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cruse) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →